No Data
The USA's tariff "nuclear bomb" is coming! The Global manufacturing industry is trembling, and factory activities are shrinking in many regions.
Due to companies preparing to respond to the new round of tariffs in the USA, factory activities worldwide from Japan to the United Kingdom declined in March.
Hagoromo Foods To Go Ex-Dividend On March 28th, 2025 With 30 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Hagoromo Foods(2831.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 30 JPY dividend per share. The ex-
BOJ Governor Suggests Food Inflation Could Lead to Rate Hike -- Update
Japan's Food Inflation Is Becoming Harder for BOJ to Overlook
Recruit Holdings has revised its 2025/3 operating profit upward to 488 billion yen from 442.7 billion yen.
Recruit Holdings <6098> announced a revision of its financial estimates for the fiscal year ending in March 2025. Revenue has been revised upward from 3 trillion 468.7 billion yen to 3 trillion 560 billion yen, and operating profit has been revised upward from 442.7 billion yen to 488 billion yen. The HR Technology business, centered around the US job search site "Indeed," is performing well, contributing to increased revenue per paid job advertisement. Matching & solutions such as the real estate site "SUUMO" and the beauty reservation site "Hot Pepper View Inc" are also contributing.
Key points of the PTS on the 12th = Rakuten Bank, GMO R&A, Sumitomo Construction.
▽ Rakuten Bank <5838.T>, Earnings Reports and Financial Estimates revisions ▽ GMO R&A <3695.T>, Earnings Reports and Financial Estimates and Dividends forecast revisions as well as the introduction of a Shareholder benefit system ▽ Mizuho Construction <1821.T>, Earnings Reports and Financial Estimates revisions ▽ Japan Electrical Construction <1950.T>, Dividend increase and share buyback ▽ JGC HD <1963.T>, Earnings Reports and Financial Estimates revisions ▽ Sasmmed <4263.T>, achievement of milestones related to a joint research and development and sales agreement with Aska Pharmaceutical ▽ SIGG <
